0001209191-12-027017.txt : 20120509 0001209191-12-027017.hdr.sgml : 20120509 20120509163712 ACCESSION NUMBER: 0001209191-12-027017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120507 FILED AS OF DATE: 20120509 DATE AS OF CHANGE: 20120509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12826260 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-05-07 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2012-05-07 4 M 0 3300 11.27 A 151536 D Common Stock 2012-05-07 4 M 0 51200 16.32 A 202736 D Common Stock 2012-05-07 4 M 0 25000 18.93 A 227736 D Common Stock 2012-05-07 4 S 0 54500 52.13 D 173236 D Common Stock 2012-05-07 4 S 0 25000 55.00 D 148236 D Common Stock 4367 I 401(k) Stock Option 11.27 2012-05-07 4 M 0 3300 0.00 D 2014-10-06 Common Stock 3300 0 D Stock Option 16.32 2012-05-07 4 M 0 51200 0.00 D 2013-07-14 Common Stock 51200 48800 D Stock Option 18.93 2012-05-07 4 M 0 25000 0.00 D 2018-02-16 Common Stock 25000 40500 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Fully vested. David T. Howton, Attorney-In-Fact 2012-05-09